162 related articles for article (PubMed ID: 23084576)
41. Comparison of drug-eluting stents with bare metal stents implantation for the treatment of acute ST-elevation myocardial infarction: 2-year clinical outcomes from single-center registry.
Li Y; Han YL; Zhang QY; Guan SY; Wang XZ; Jing QM; Ma YY; Wang G; Wang B; Deng J
Chin Med J (Engl); 2011 Mar; 124(6):825-30. PubMed ID: 21518587
[TBL] [Abstract][Full Text] [Related]
42. Clinical outcomes following drug-eluting versus bare metal stent implantation for lesion subsets excluded from pivotal clinical trials: findings from the GHOST Study (Guthrie Health System Off-Label StenT Study).
Harjai KJ; Orshaw P; Shenoy C; Acharji S; Sporn D; Aboufares A; Stapleton D
J Interv Cardiol; 2008 Aug; 21(4):315-24. PubMed ID: 18754967
[TBL] [Abstract][Full Text] [Related]
43. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry.
Garg P; Normand SL; Silbaugh TS; Wolf RE; Zelevinsky K; Lovett A; Varma MR; Zhou Z; Mauri L
Circulation; 2008 Nov; 118(22):2277-85, 7p following 2285. PubMed ID: 19001019
[TBL] [Abstract][Full Text] [Related]
44. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
[TBL] [Abstract][Full Text] [Related]
45. Long-term clinical benefit of drug-eluting stents over bare-metal stents in diabetic patients with de novo left main coronary artery disease: results from a real-world multicenter registry.
Capodanno D; Di Salvo ME; Palmerini T; Sheiban I; Margheri M; Vecchi G; Sangiorgi G; Piovaccari G; Bartorelli A; Briguori C; Ardissino D; Di Pede F; Ramondo A; Inglese L; Petronio AS; Bolognese L; Benassi A; Palmieri C; Filippone V; De Servi S; Tamburino C
Catheter Cardiovasc Interv; 2009 Feb; 73(3):310-6. PubMed ID: 19214964
[TBL] [Abstract][Full Text] [Related]
46. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.
Migliorini A; Moschi G; Vergara R; Parodi G; Carrabba N; Antoniucci D
Catheter Cardiovasc Interv; 2006 Mar; 67(3):344-8. PubMed ID: 16489559
[TBL] [Abstract][Full Text] [Related]
47. Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).
Patel MR; Pfisterer ME; Betriu A; Widmisky P; Holmes DR; O'Neill WW; Stebbins A; Van de Werf F; Armstrong PW; Granger CB;
Am J Cardiol; 2009 Jan; 103(2):181-6. PubMed ID: 19121433
[TBL] [Abstract][Full Text] [Related]
48. Long-term outcomes of drug-eluting versus bare-metal stent implantation in patients with chronic total coronary artery occlusions.
Han YL; Zhang J; Li Y; Wang SL; Jing QM; Yi XH; Ma YY; Luan B; Wang G; Wang B
Chin Med J (Engl); 2009 Mar; 122(6):643-7. PubMed ID: 19323927
[TBL] [Abstract][Full Text] [Related]
49. Metabolic syndrome does not impact long-term survival in patients with acute myocardial infarction after successful percutaneous coronary intervention with drug-eluting stents.
Won KB; Kim BK; Chang HJ; Shin DH; Kim JS; Ko YG; Choi D; Ha JW; Hong MK; Jang Y
Catheter Cardiovasc Interv; 2014 Apr; 83(5):713-20. PubMed ID: 23934969
[TBL] [Abstract][Full Text] [Related]
50. Percutaneous treatment of multivessel coronary disease in the drug eluting stent era: comparison of bare-metal stents, drug-eluting stents and a mixed approach in a large multicentre registry.
Varani E; Saia F; Balducelli M; Guastaroba P; Marrozzini C; Tarantino F; Passerini F; Sangiorgio P; Percoco G; Grilli R; Marzocchi A; Maresta A
EuroIntervention; 2007 Feb; 2(4):474-80. PubMed ID: 19755287
[TBL] [Abstract][Full Text] [Related]
51. Comparison of clinical outcomes between octogenarians and non-octogenarians with acute myocardial infarction in the drug-eluting stent era: analysis of the Korean Acute Myocardial Infarction Registry.
Yamanaka F; Jeong MH; Saito S; Ahn Y; Chae SC; Hur SH; Hong TJ; Kim YJ; Seong IW; Chae JK; Rhew JY; Chae IH; Cho MC; Bae JH; Rha SW; Kim CJ; Choi D; Jang YS; Yoon J; Chung WS; Cho JG; Seung KB; Park SJ;
J Cardiol; 2013 Oct; 62(4):210-6. PubMed ID: 23731919
[TBL] [Abstract][Full Text] [Related]
52. Impact of ad hoc percutaneous coronary intervention with drug-eluting stents in angina patients.
Kim YH; Park DW; Ahn JM; Park GM; Cho YR; Lee JY; Kim WJ; Yun SC; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ;
EuroIntervention; 2013 May; 9(1):110-7. PubMed ID: 23685299
[TBL] [Abstract][Full Text] [Related]
53. Determinants of bare-metal stent use in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Parikh PB; Jeremias A; Naidu SS; Brener SJ; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
J Invasive Cardiol; 2013 Mar; 25(3):114-7. PubMed ID: 23468438
[TBL] [Abstract][Full Text] [Related]
54. Acute multivessel revascularization improves 1-year outcome in ST-elevation myocardial infarction: a nationwide study cohort from the AMIS Plus registry.
Jeger R; Jaguszewski M; Nallamothu BN; Lüscher TF; Urban P; Pedrazzini GB; Erne P; Radovanovic D;
Int J Cardiol; 2014 Mar; 172(1):76-81. PubMed ID: 24461983
[TBL] [Abstract][Full Text] [Related]
55. Proximal coronary artery intervention: stent thrombosis, restenosis and death.
Calais F; Lagerqvist B; Leppert J; James SK; Fröbert O
Int J Cardiol; 2013 Dec; 170(2):227-32. PubMed ID: 24211065
[TBL] [Abstract][Full Text] [Related]
56. Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial).
Valgimigli M; Tricoci P; Huang Z; Aylward PE; Armstrong PW; Van de Werf F; Leonardi S; White HD; Widimsky P; Harrington RA; Cequier A; Chen E; Lokhnygina Y; Wallentin L; Strony J; Mahaffey KW; Moliterno DJ
Am J Cardiol; 2014 Sep; 114(5):665-73. PubMed ID: 25129064
[TBL] [Abstract][Full Text] [Related]
57. Impact of diabetes on long-term mortality following multivessel percutaneous interventions: an insight into optimal statistical analysis.
Agarwal S; Bajaj NS; Zaman T; Banerjee S; Tuzcu EM; Ellis SG; Kapadia SR
Int J Cardiol; 2013 Sep; 167(5):2120-5. PubMed ID: 22703903
[TBL] [Abstract][Full Text] [Related]
58. Impact on in-hospital outcomes with drug-eluting stents versus bare-metal stents (from 665,804 procedures).
Badheka AO; Arora S; Panaich SS; Patel NJ; Patel N; Chothani A; Mehta K; Deshmukh A; Singh V; Savani GT; Agnihotri K; Grover P; Lahewala S; Patel A; Bambhroliya C; Kondur A; Brown M; Elder M; Kaki A; Mohammad T; Grines C; Schreiber T
Am J Cardiol; 2014 Dec; 114(11):1629-37. PubMed ID: 25439448
[TBL] [Abstract][Full Text] [Related]
59. Impact of the first-generation drug-eluting stent implantation on periprocedural myocardial injury in patients with stable angina pectoris.
Okada T; Yoshikawa D; Ishii H; Matsumoto M; Hayakawa S; Matsudaira K; Tanaka M; Kumagai S; Hayashi M; Ando H; Amano T; Murohara T
J Cardiol; 2012 Oct; 60(4):264-9. PubMed ID: 22738692
[TBL] [Abstract][Full Text] [Related]
60. Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis.
Chang TI; Montez-Rath ME; Tsai TT; Hlatky MA; Winkelmayer WC
J Am Coll Cardiol; 2016 Mar; 67(12):1459-1469. PubMed ID: 27012407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
